March 28, 2023
ATA Action's Letter to the DEA Re: Expansion of Induction of Buprenorphine via Telemedicine Encounter
ATA Action Letter
ATA Action submitted comments in response to the Drug Enforcement Administration (DEA)’s proposed rules regarding expansion of induction of buprenorphine via telemedicine